QUADRABIND

Indications

• Infections (topical treatment)
• Wound care (as an antiseptic)
• Ear infections (as an ear drop solution)
• Acid-base balance in metabolic acidosis

Dosage

Children: Refer to established guidelines as dosage may vary based on the formulation and indication.

Adults: Refer to established guidelines as dosage may vary based on the formulation and indication.

Mechanism of action

Acetic acid exerts its effects primarily through its ability to lower pH levels, creating an acidic environment which is inhospitable to many pathogens. It can disrupt the integrity of microbial cell membranes, leading to cell lysis and death. Additionally, acetic acid can promote the healing of wounds and enhance the absorption of certain medications when used as a solvent.

Pharmacodynamics

The pharmacodynamics of acetic acid involve its interaction with biological systems, leading to changes in cellular functions. Its acidic nature helps in the denaturation of proteins and disruption of microbial metabolism. This contributes to its antibacterial and antifungal activities, making it effective against a range of pathogens.

Pharmacokinetics

Acetic acid is rapidly absorbed in the gastrointestinal tract when ingested. It is metabolized primarily in the liver, converting to acetyl CoA and subsequently entering various metabolic pathways including the citric acid cycle. The elimination half-life varies but is generally short, with excretion occurring mainly via urine. When applied topically, absorption is minimal, and local effects are predominant.

Pregnancy

The safety of acetic acid during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is no specific information available regarding the use of acetic acid during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed in a well-ventilated area.

Dosage

Children: Refer to established pharmacological guidelines and clinical protocols for specific dosing information, as no standardized paediatric dosage is available.

Adults: Refer to established pharmacological guidelines and clinical protocols for specific dosing information, as no standardized adult dosage is available.

Mechanism of action

Formic acid exerts its effects through the inhibition of certain metabolic processes. It can act as a metabolic poison by interfering with the mitochondrial respiratory chain, leading to disruptions in energy production. Additionally, it has properties that can induce apoptosis in certain cell types, contributing to its potential cytotoxic effects.

Pharmacodynamics

Formic acid primarily acts as a corrosive agent, capable of causing tissue damage upon exposure. It has antibacterial properties, which may help in reducing microbial load in certain applications. The acid's effects can vary based on concentration and exposure route, influencing its clinical utility and safety profile.

Pharmacokinetics

Formic acid is rapidly absorbed following exposure, with systemic effects observed after ingestion, inhalation, or dermal contact. It is metabolized primarily in the liver, where it can be converted to carbon dioxide and water. The elimination half-life may vary depending on the route of exposure and individual metabolic factors, but it is generally considered to be rapidly eliminated from the body.

Pregnancy

There is limited data on the use of formic acid during pregnancy. Caution is advised.

Breast-feeding

Limited data is available regarding the excretion of formic acid in breast milk. Caution is recommended.

Storage

Formic acid should be stored in a cool, dry place, away from incompatible substances and in a tightly sealed container.

Indications

• Pain relief
• Anti-inflammatory treatment
• Management of osteoarthritis
• Management of rheumatoid arthritis
• Treatment of dysmenorrhea
• Postoperative pain management

Dosage

Children: Refer to specific propionic acid derivative product monographs for paediatric dosing as it varies by formulation and condition treated.

Adults: Refer to specific propionic acid derivative product monographs for adult dosing as it varies by formulation and condition treated.

Mechanism of action

Propionic acid and its derivatives exert their effects primarily through the inhibition of cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins. This results in reduced inflammation, pain, and fever. By blocking COX-1 and COX-2 pathways, propionic compounds modulate the inflammatory response and provide analgesic effects.

Pharmacodynamics

Propionic compounds have a rapid onset of action, with effects noticeable within 30 minutes to an hour after administration. The anti-inflammatory effects are dose-dependent, and the duration of action typically lasts for several hours. The analgesic properties are also evident in acute and chronic pain management, providing relief from conditions such as arthritis, menstrual pain, and musculoskeletal disorders.

Pharmacokinetics

After oral administration, propionic acid is rapidly absorbed from the gastrointestinal tract. It is primarily metabolized in the liver, undergoing glucuronidation and oxidation. The elimination half-life of propionic derivatives varies but generally ranges from 1 to 4 hours. These substances are excreted primarily through urine, with a small fraction eliminated in feces. Due to their short half-lives, multiple dosing may be required to maintain therapeutic levels.

Contra-indications

• Hypersensitivity to propionic acid or its derivatives
• Active peptic ulcer disease
• Severe renal impairment

Adverse effects

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Dizziness
• Headache
• Rash
• Tinnitus
• Hepatotoxicity (rare)

Interactions

• Increased risk of gastrointestinal bleeding with NSAIDs
• Inhibition of renal excretion of certain drugs (e.g., lithium)
• Potential additive effects with other central nervous system depressants

Precautions

• Use with caution in patients with renal or hepatic impairment
• Monitor for signs of gastrointestinal bleeding in long-term use
• Caution in patients with asthma, as propionic acid derivatives may exacerbate symptoms

Pregnancy

Use in pregnancy only if clearly needed. Animal studies have shown adverse effects. There is limited data on human pregnancy.

Breast-feeding

Use with caution while breastfeeding. Propionic acid and its derivatives may pass into breast milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Oral tablets
• Oral suspension
• Topical formulations (creams, gels)